MEC Practice Academy 11.19
News|Videos|May 19, 2025

Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill

Fact checked by: Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a pharmaceutical manufacturer. Scott Brunner, CEO of the Alliance for Pharmacy Compounding offers this tutorial and examples of how compounding pharmacists meet patient demand for necessary drugs.


Related to this article

Is more health care access always better?: ©Yodiyim - stock.adobe.com
In 590,282 California heart attack hospitalizations, a new PCI-capable facility within a 30-minute drive lowered 30-day mortality 20% in communities without prior access but did not change survival where the procedure was already available.